Visualizing the beta interferon response in mice during infection with influenza a viruses expressing or lacking nonstructural protein 1

Journal of Virology

Volumn 87, Issue 12, 2013, Pages 6925-6930

  Kallfass, Carsten ^a   Staeheli, Peter ^a   Lienenklaus, Stefan ^b   Weiss, Siegfried ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CELL MARKER; GLYCOPROTEIN P 15095; LUCIFERASE; NONSTRUCTURAL PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BULK DENSITY; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLUENZA A; INNATE IMMUNITY; LUCIFERASE GENE; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS MUTANT; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD11C; EPITHELIAL CELLS; IMMUNITY, INNATE; INFLUENZA A VIRUS; INTERFERON-BETA; LUCIFERASES; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; VIRAL NONSTRUCTURAL PROTEINS;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 84878567290     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00283-13     Document Type: Article

References (37)

1. Haller O, Kochs G, Weber F. 2006. The interferon response circuit:induction and suppression by pathogenic viruses. Virology 344:119 -130.
2. Genin P, Vaccaro A, Civas A. 2009. The role of differential expression ofhuman interferon-α genes in antiviral immunity. Cytokine Growth FactorRev. 20:283-295.
3. Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P. 2012. Visualizing production of Beta interferon by astrocytes and microglian brain of la crosse virus-infected mice. J. Virol. 86:11223-11230.
4. Solodova E, Jablonska J, Weiss S, Lienenklaus S. 2011. Production ofIFN-beta during Listeria monocytogenes infection is restricted to monocyte/macrophage lineage. PLoS One 6:e18543. doi:10.1371/journal.pone.0018543.
5. Erlandsson L, Blumenthal R, Eloranta ML, Engel H, Alm G, Weiss S,Leanderson T. 1998. Interferon-beta is required for interferon-alpha productionin mouse fibroblasts. Curr. Biol. 8:223-226.
6. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors.Nat. Rev. Immunol. 8:559-568.
7. Versteeg GA, Garcia-Sastre A. 2010. Viral tricks to grid-lock the type I interferon system. Curr. Opin. Microbiol. 13:508 -516.
8. Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, Morii E, Aozasa K, Kawai T, Akira S. 2007. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity27:240 -252.
9. Lienenklaus S, Cornitescu M, Zietara N, Lyszkiewicz M, Gekara N,Jablonska J, Edenhofer F, Rajewsky K, Bruder D, Hafner M, Staeheli P,Weiss S. 2009. Novel reporter mouse reveals constitutive and inflammatoryexpression of IFN-beta in vivo. J. Immunol. 183:3229 -3236.
10. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, Ruggli N, Summerfield A, Pavlovic J, Stech J, Staeheli P. 2007. Properties of H7N7influenza A virus strain SC35M lacking interferon antagonist NS1 in miceand chickens. J. Gen. Virol. 88:1403-1409.
11. Haller O, Staeheli P, Kochs G. 2007. Interferon-induced Mx proteins inantiviral host defense. Biochimie 89:812- 818.
12. Bailey CC, Huang IC, Kam C, Farzan M. 2012. Ifitm3 limits the severityof acute influenza in mice. PLoS Pathog. 8:e1002909. doi:10.1371/journal.ppat.1002909.
13. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, RyanBJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, FarzanM, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance toinfluenzaAH1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254.
14. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS. 2002. Induction of proinflammatory cytokines inhuman macrophages by influenza A (H5N1) viruses: a mechanism for theunusual severity of human disease? Lancet 360:1831-1837.
15. Hogner K, Wolff T, Pleschka S, Plog S, Gruber AD, Kalinke U, WalmrathHD, Bodner J, Gattenlohner S, Lewe-Schlosser P, Matrosovich M,Seeger W, Lohmeyer J, Herold S. 2013. Macrophage-expressed IFN-betacontributes to apoptotic alveolar epithelial cell injury in severe influenzavirus pneumonia. PLoS Pathog. 9:e1003188. doi:10.1371/journal.ppat.1003188.
16. Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS, Jr, Bakaletz LO,Durbin RK, Flano E, Durbin JE. 2007. Differential type I interferoninduction by respiratory syncytial virus and influenza a virus in vivo. J.Virol. 81:9790 -9800.
17. Kaminski MM, Ohnemus A, Cornitescu M, Staeheli P. 2012. Plasmacytoiddendritic cells and Toll-like receptor 7-dependent signalling promoteefficient protection of mice against highly virulent influenza A virus.J. Gen. Virol. 93:555-559.
18. Phipps-Yonas H, Seto J, Sealfon SC, Moran TM, Fernandez-Sesma A.2008. Interferon-beta pretreatment of conventional and plasmacytoid humandendritic cells enhances their activation by influenza virus. PLoSPathog. 4:e1000193. doi:10.1371/journal.ppat.1000193.
19. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. 1999.Conditional gene targeting in macrophages and granulocytes usingLysMcre mice. Transgenic Res. 8:265-277.
20. Tiozzo C, De Langhe S, Yu M, Londhe VA, Carraro G, Li M, Li C, XingY, Anderson S, Borok Z, Bellusci S, Minoo P. 2009. Deletion of Ptenexpands lung epithelial progenitor pools and confers resistance to airwayinjury. Am. J. Respir. Crit. Care Med. 180:701-712.
21. Caton ML, Smith-Raska MR, Reizis B. 2007. Notch-RBP-J. signalingcontrols the homeostasis of CD8- dendritic cells in the spleen. J. Exp.Med. 204:1653-1664.
22. Kochs G, Martinez-Sobrido L, Lienenklaus S, Weiss S, Garcia-Sastre A,Staeheli P. 2009. Strong interferon-inducing capacity of a highly virulentvariant of influenza A virus strain PR8 with deletions in the NS1 gene. J.Gen. Virol. 90:2990 -2994.
23. Kasper M, Behrens J, Schuh D, Muller M. 1995. Distribution of Ecadherinand Ep-CAM in the human lung during development and afterinjury. Histochem. Cell Biol. 103:281-286.
24. Paine R, III, Morris SB, Jin H, Wilcoxen SE, Phare SM, Moore BB,Coffey MJ, Toews GB. 2001. Impaired functional activity of alveolarmacrophages from GM-CSF-deficient mice. Am. J. Physiol. Lung Cell.Mol. Physiol. 281:L1210 -L1218.
25. Simon RH, McCoy JP, Jr, Chu AE, Dehart PD, Goldstein IJ. 1986.Binding of Griffonia simplicifolia I lectin to rat pulmonary alveolar macrophagesand its use in purifying type II alveolar epithelial cells. Biochim.Biophys. Acta 885:34-42.
26. Siracusa MC, Reece JJ, Urban JF, Jr, Scott AL. 2008. Dynamics of lungmacrophage activation in response to helminth infection. J. Leukoc. Biol.84:1422-1433.
27. Moltedo B, Lopez CB, Pazos M, Becker MI, Hermesh T, Moran TM.2009. Stealth influenza virus replication precedes the initiation of adaptiveimmunity. J. Immunol. 183:3569 -3573.
28. Rand U, Rinas M, Schwerk J, Nohren G, Linnes M, Kroger A, Flossdorf M, Kaly-Kullai K, Hauser H, Hofer T, Koster M. 2012. Multi-layeredstochasticity and paracrine signal propagation shape the type-I interferonresponse. Mol. Syst. Biol. 8:584.
29. Zhao M, Zhang J, Phatnani H, Scheu S, Maniatis T. 2012. Stochasticexpression of the interferon-beta gene. PLoS Biol. 10:e1001249. doi:10.1371/journal.pbio.1001249.
30. Helft J, Manicassamy B, Guermonprez P, Hashimoto D, Silvin A,Agudo J, Brown BD, Schmolke M, Miller JC, Leboeuf M, Murphy KM,Garcia-Sastre A, Merad M. 2012. Cross-presenting CD103+dendriticcells are protected from influenza virus infection. J. Clin. Invest. 122:4037-4047.
31. Ho AW, Prabhu N, Betts RJ, Ge MQ, Dai X, Hutchinson PE, Lew FC,Wong KL, Hanson BJ, Macary PA, Kemeny DM. 2011. Lung CD103+dendritic cells efficiently transport influenza virus to the lymph node andload viral antigen onto MHC class I for presentation to CD8 T cells. J.Immunol. 187:6011- 6021.
32. Jakubzick C, Bogunovic M, Bonito AJ, Kuan EL, Merad M, Randolph GJ. 2008. Lymph-migrating, tissue-derived dendritic cells are minor constituentswithin steady-state lymph nodes. J. Exp. Med. 205:2839 -2850.
33. Kato A, Schleimer RP. 2007. Beyond inflammation: airway epithelial cellsare at the interface of innate and adaptive immunity. Curr. Opin. Immunol.19:711-720.
34. Kohlmeier JE, Woodland DL. 2009. Immunity to respiratory viruses.Annu. Rev. Immunol. 27:61- 82.
35. McGill J, Heusel JW, Legge KL. 2009. Innate immune control andregulation of influenza virus infections. J. Leukoc. Biol. 86:803- 812.
36. Huang Z, Krishnamurthy S, Panda A, Samal SK. 2003. Newcastle diseasevirus V protein is associated with viral pathogenesis and functions as analpha interferon antagonist. J. Virol. 77:8676-8685.
37. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N,Palese P, Garcia-Sastre A, Basler CF. 2003. Newcastle disease virus(NDV)-based assay demonstrates interferon-antagonist activity for theNDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77:1501-1511.